Imspex Diagnostics’ proprietary GC-IMS analytical technology platform has built a legacy of being a versatile, accurate and robust analytical research tool in situations where compound combinations are complex and/ or concentrations are low. Much of this legacy has centred around volatile compounds in industrial and more recently environmental and food production settings. The ultra-highly sensitive […]
Efforts to develop a quick and non-invasive breath test for the presence of COVID-19 are underway in Vancouver, British Columbia. Imspex’s BreathSpec® is one of a battery of tests that are being used by Dr Renelle Myers and her Vancouver Coastal Health team in their work to develop a breath test that identifies the possible […]
Antibiotic Resistance Antibiotic resistance has become an ever-growing concern for society today due to its increasing effect on mortality and morbidity. For many years now there has been a huge reliance on antibiotics and hence over prescription by healthcare professionals, and this has ultimately led to the growing problem of antibiotics losing their effectiveness on […]
Discover our stand-alone Ion Mobility Spectrometer The stand-alone IMS (Ion Mobility Spectrometer) by G.A.S. mbH enables the use of the IMS technology in very demanding gas phase applications where high separation capabilities and/or sensitivity are needed. Compared to other detectors the IMS offers a second dimension of separation and by that full orthoganality so that […]
The Imspex Group’s BreathSpec® technology is well-placed to play a leading role in combatting antimicrobial resistance by helping healthcare practitioners to differentiate between bacterial and viral causes of respiratory infection. This would better allow the right antibiotic to be prescribed to the right patient at the right time and in the right dose , thereby […]
Findings of a feasibility study into the potential for breath analysis to help doctors to differentiate between COVID-19 and other respiratory conditions were published in The Lancet on 24 October 2020. The Imspex Group’s BreathSpec® instrument showed clusters of breath compounds reflecting the effects of COVID-19’s multi-system nature. Similar clusters were found independently across research […]
IMSPEX is pleased to have completed a Welsh Government- and ERDF-backed Technical and Commercial Feasibility (TCF) study focused on translating innovative and high-impact medical technology into solutions that can be implemented and scaled to generate health, wellbeing and economic prosperity within Wales. This study contributed to the Welsh Government’s aim of ensuring that resources an […]
BreathSpec system and the BBC – How should we deal with a chemical attack? The BreathSpec system has been gaining much publicity recently. Read about and watch a video that explains how our BreathSpec system can be used in dangerous situations that could potentially help save many lives. BBC’s Frank Gardner gets his breath sampled […]
BreathSpec: Gas Chromatograph- Ion Mobility Spectrometer for VOC Trace Detection The BreathSpec® is a combination of a classical gas chromatograph coupled to an ion mobility spectrometer (GCxIMS). Dual physical separation of volatile compounds together with the outstanding sensitivity of the IMS allows the detection and quantification of compounds in complex matrices down to the low […]
Rapid Monitoring of Dimethyl Sulfate (DMS) in Chemical Plants using GC-IMS Technology Toxic industrial chemicals (TICs) or materials (TIMs) are substances that exhibit harmful effects on humans and are common in manufacturing facilities, chemical plants, maintenance areas or general storage areas. Exposure to those chemicals are seriously harmful especially after multiple low-level exposures. Dimethyl sulfate […]